8-(2,5-dimethylpyrazol-3-yl)-N-[(6-fluoro-3,4-dihydro-2H-chromen-5-yl)methyl]-2-methylimidazo[1,2-c]pyrimidin-5-amine
C22H23FN6O — CID 157085020
Data last refreshed: (MolForge compound catalog, from PubChem)
About 8-(2,5-dimethylpyrazol-3-yl)-N-[(6-fluoro-3,4-dihydro-2H-chromen-5-yl)methyl]-2-methylimidazo[1,2-c]pyrimidin-5-amine
8-(2,5-dimethylpyrazol-3-yl)-N-[(6-fluoro-3,4-dihydro-2H-chromen-5-yl)methyl]-2-methylimidazo[1,2-c]pyrimidin-5-amine (PubChem CID 157085020) has the molecular formula C22H23FN6O and a molecular weight of 406.47 g/mol. Its IUPAC name is 8-(2,5-dimethylpyrazol-3-yl)-N-[(6-fluoro-3,4-dihydro-2H-chromen-5-yl)methyl]-2-methylimidazo[1,2-c]pyrimidin-5-amine.
Molecular Properties
| Compound Name | 8-(2,5-dimethylpyrazol-3-yl)-N-[(6-fluoro-3,4-dihydro-2H-chromen-5-yl)methyl]-2-methylimidazo[1,2-c]pyrimidin-5-amine |
|---|---|
| PubChem CID | 157085020 |
| Molecular Formula | C22H23FN6O |
| Molecular Weight | 406.47 g/mol |
| Exact Mass | 406.19 |
| IUPAC Name | 8-(2,5-dimethylpyrazol-3-yl)-N-[(6-fluoro-3,4-dihydro-2H-chromen-5-yl)methyl]-2-methylimidazo[1,2-c]pyrimidin-5-amine |
| SMILES | Cc1cn2c(NCc3c(F)ccc4c3CCCO4)ncc(-c3cc(C)nn3C)c2n1 |
| InChI | InChI=1S/C22H23FN6O/c1-13-9-19(28(3)27-13)17-11-25-22(29-12-14(2)26-21(17)29)24-10-16-15-5-4-8-30-20(15)7-6-18(16)23/h6-7,9,11-12H,4-5,8,10H2,1-3H3,(H,24,25) |
| InChIKey | ZVIMFBOZMBMEBJ-UHFFFAOYSA-N |
| XLogP | 3.82 |
| TPSA | 69.27 Ų |
| H-Bond Donors | 1 |
| H-Bond Acceptors | 7 |
| Rotatable Bonds | 4 |
| Heavy Atoms | 30 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 406.47 |
| LogP ≤ 5 | 3.82 |
| H-Bond Donors ≤ 5 | 1 |
| H-Bond Acceptors ≤ 10 | 7 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 157085020 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.